A Study to Assess Sinus Stenting to Manage Cerebrospinal Fluid Leak


About this study

The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid (CSF) leak in patients with idiopathic intracranial hypertension presenting with CSF leak.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients that have had a cerebrospinal fluid (CSF) leak and have had a dural sinus stent placed .

Exclusion Criteria: 

  • Patients that have not had a CSF leak.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Giuseppe Lanzino, M.D.

Contact us for the latest status

Contact information:

Roanna Vine R.N.



More information


Publications are currently not available

Mayo Clinic Footer